Other Stories

U.S. gives emergency authorization to J&J vaccine Updated: 2021-02-28 12:45:15 KST

The U.S. Food and Drug Administration has given emergency approval to the vaccine developed by Johnson and Johnson, giving America a third vaccine in its fight against the virus.
The J&J vaccine can be administered in just one dose, though they're studying the impact of giving a second one.
The company says it expects that 20 million doses will be available by the end of March.
An analysis by the FDA found it to be 86 percent effective against severe disease and 72 percent effective against moderate to severe disease.
Those numbers, however, were lower for the South Africa variant.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.